Research Institute of Neuromuscular and Neurodegenerative Diseases and Department of Neurology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
GrandOmics Biosciences, No.56 Zhichun Road, Haidian District, Beijing, 100098, China.
BMC Genomics. 2024 May 31;25(1):538. doi: 10.1186/s12864-024-10433-9.
Mitochondrial diseases (MDs) can be caused by single nucleotide variants (SNVs) and structural variants (SVs) in the mitochondrial genome (mtDNA). Presently, identifying deletions in small to medium-sized fragments and accurately detecting low-percentage variants remains challenging due to the limitations of next-generation sequencing (NGS).
In this study, we integrated targeted long-range polymerase chain reaction (LR-PCR) and PacBio HiFi sequencing to analyze 34 participants, including 28 patients and 6 controls. Of these, 17 samples were subjected to both targeted LR-PCR and to compare the mtDNA variant detection efficacy.
Among the 28 patients tested by long-read sequencing (LRS), 2 patients were found positive for the m.3243 A > G hotspot variant, and 20 patients exhibited single or multiple deletion variants with a proportion exceeding 4%. Comparison between the results of LRS and NGS revealed that both methods exhibited similar efficacy in detecting SNVs exceeding 5%. However, LRS outperformed NGS in detecting SNVs with a ratio below 5%. As for SVs, LRS identified single or multiple deletions in 13 out of 17 cases, whereas NGS only detected single deletions in 8 cases. Furthermore, deletions identified by LRS were validated by Sanger sequencing and quantified in single muscle fibers using real-time PCR. Notably, LRS also effectively and accurately identified secondary mtDNA deletions in idiopathic inflammatory myopathies (IIMs).
LRS outperforms NGS in detecting various types of SNVs and SVs in mtDNA, including those with low frequencies. Our research is a significant advancement in medical comprehension and will provide profound insights into genetics.
线粒体疾病(MDs)可能由线粒体基因组(mtDNA)中的单核苷酸变异(SNVs)和结构变异(SVs)引起。目前,由于下一代测序(NGS)的限制,识别小到中等大小片段中的缺失并准确检测低比例的变体仍然具有挑战性。
在这项研究中,我们整合了靶向长距离聚合酶链反应(LR-PCR)和 PacBio HiFi 测序,分析了 34 名参与者,包括 28 名患者和 6 名对照。其中,17 个样本同时进行了靶向 LR-PCR 和比较 mtDNA 变体检测效果。
在通过长读测序(LRS)测试的 28 名患者中,发现 2 名患者存在 m.3243 A>G 热点变异阳性,20 名患者表现出单一或多种缺失变异,比例超过 4%。LRS 与 NGS 结果的比较表明,两种方法在检测超过 5%的 SNVs 时具有相似的效果。然而,LRS 在检测比例低于 5%的 SNVs 方面优于 NGS。对于 SVs,LRS 在 17 例中有 13 例识别出单一或多种缺失,而 NGS 仅在 8 例中检测到单一缺失。此外,LRS 通过 Sanger 测序和使用实时 PCR 在单个肌肉纤维中定量验证了缺失。值得注意的是,LRS 还可以有效地和准确地识别特发性炎症性肌病(IIMs)中的继发性 mtDNA 缺失。
LRS 在检测 mtDNA 中的各种类型的 SNVs 和 SVs,包括低频的 SNVs 和 SVs 方面优于 NGS。我们的研究是医学理解方面的重大进展,并将为遗传学提供深刻的见解。